Concepts (253)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Meninges | 17 | 2023 | 190 | 5.320 |
Why?
|
| Nociceptors | 25 | 2021 | 432 | 4.940 |
Why?
|
| Post-Traumatic Headache | 7 | 2020 | 71 | 4.020 |
Why?
|
| Migraine Disorders | 24 | 2023 | 1620 | 3.440 |
Why?
|
| Dura Mater | 12 | 2023 | 291 | 2.970 |
Why?
|
| Cortical Spreading Depression | 8 | 2021 | 276 | 2.720 |
Why?
|
| Mast Cells | 13 | 2019 | 1544 | 2.270 |
Why?
|
| Hyperalgesia | 9 | 2020 | 502 | 1.870 |
Why?
|
| Rats, Sprague-Dawley | 36 | 2021 | 8300 | 1.430 |
Why?
|
| Pain Threshold | 5 | 2020 | 585 | 1.360 |
Why?
|
| Trigeminal Nerve | 7 | 2018 | 249 | 1.350 |
Why?
|
| Head Injuries, Closed | 3 | 2020 | 136 | 1.300 |
Why?
|
| Calcitonin Gene-Related Peptide | 6 | 2020 | 305 | 1.260 |
Why?
|
| Trigeminal Ganglion | 8 | 2014 | 186 | 1.170 |
Why?
|
| Pain | 13 | 2019 | 4961 | 1.050 |
Why?
|
| Neurons, Afferent | 5 | 2016 | 508 | 1.030 |
Why?
|
| Rats | 37 | 2021 | 24265 | 1.000 |
Why?
|
| Afferent Pathways | 5 | 2018 | 302 | 0.950 |
Why?
|
| Cell Degranulation | 3 | 2019 | 287 | 0.940 |
Why?
|
| Physical Stimulation | 12 | 2019 | 525 | 0.930 |
Why?
|
| Sumatriptan | 6 | 2016 | 66 | 0.860 |
Why?
|
| Cyclooxygenase 1 | 3 | 2012 | 104 | 0.820 |
Why?
|
| Brain Concussion | 3 | 2018 | 1318 | 0.800 |
Why?
|
| Tension-Type Headache | 2 | 2019 | 77 | 0.750 |
Why?
|
| Mechanoreceptors | 5 | 2011 | 186 | 0.730 |
Why?
|
| Serotonin Receptor Agonists | 5 | 2005 | 154 | 0.650 |
Why?
|
| Ophthalmic Nerve | 2 | 2018 | 43 | 0.640 |
Why?
|
| Nitric Oxide Synthase | 5 | 2001 | 916 | 0.600 |
Why?
|
| Trigeminal Neuralgia | 2 | 2017 | 113 | 0.590 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2016 | 29 | 0.580 |
Why?
|
| Sex Characteristics | 2 | 2020 | 2585 | 0.550 |
Why?
|
| Naproxen | 3 | 2018 | 99 | 0.530 |
Why?
|
| Touch Perception | 1 | 2016 | 114 | 0.520 |
Why?
|
| Craniocerebral Trauma | 1 | 2019 | 482 | 0.500 |
Why?
|
| Parietal Bone | 1 | 2014 | 47 | 0.480 |
Why?
|
| Animals | 51 | 2021 | 168561 | 0.480 |
Why?
|
| Frontal Bone | 1 | 2014 | 105 | 0.470 |
Why?
|
| Dinoprostone | 1 | 2016 | 600 | 0.460 |
Why?
|
| Serotonin | 2 | 2016 | 1024 | 0.460 |
Why?
|
| Periosteum | 1 | 2014 | 138 | 0.460 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 2 | 2013 | 625 | 0.430 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2014 | 541 | 0.420 |
Why?
|
| Estrous Cycle | 1 | 2012 | 73 | 0.420 |
Why?
|
| Peripheral Nervous System Diseases | 3 | 2005 | 700 | 0.420 |
Why?
|
| Trigeminal Caudal Nucleus | 1 | 2011 | 18 | 0.410 |
Why?
|
| Vasodilation | 2 | 2018 | 944 | 0.410 |
Why?
|
| Headache | 2 | 2023 | 1219 | 0.400 |
Why?
|
| Sciatic Nerve | 5 | 2001 | 609 | 0.390 |
Why?
|
| Action Potentials | 7 | 2011 | 1814 | 0.370 |
Why?
|
| Migraine without Aura | 1 | 2011 | 84 | 0.370 |
Why?
|
| Cyclooxygenase 2 | 2 | 2012 | 611 | 0.370 |
Why?
|
| Neck Pain | 1 | 2011 | 179 | 0.360 |
Why?
|
| Frontal Lobe | 1 | 2016 | 1407 | 0.360 |
Why?
|
| Adaptation, Physiological | 2 | 2015 | 1310 | 0.350 |
Why?
|
| Mastocytosis | 1 | 2011 | 160 | 0.340 |
Why?
|
| Electrophysiology | 7 | 2014 | 1309 | 0.340 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2008 | 371 | 0.330 |
Why?
|
| Receptor, PAR-2 | 1 | 2008 | 32 | 0.320 |
Why?
|
| Brain | 7 | 2023 | 26343 | 0.320 |
Why?
|
| Nerve Regeneration | 2 | 2005 | 791 | 0.300 |
Why?
|
| Vasoconstrictor Agents | 1 | 2011 | 643 | 0.300 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 697 | 0.300 |
Why?
|
| Nitric Oxide | 3 | 2005 | 2128 | 0.290 |
Why?
|
| Mice, Inbred ICR | 3 | 2019 | 352 | 0.290 |
Why?
|
| Cerebral Arteries | 1 | 2009 | 492 | 0.290 |
Why?
|
| Neuronal Plasticity | 1 | 2015 | 1418 | 0.280 |
Why?
|
| Brain Injuries | 1 | 2018 | 2024 | 0.280 |
Why?
|
| Inflammation | 7 | 2018 | 10578 | 0.280 |
Why?
|
| Interleukin-1beta | 1 | 2011 | 972 | 0.270 |
Why?
|
| Arteries | 1 | 2011 | 1118 | 0.270 |
Why?
|
| Sensory Receptor Cells | 1 | 2010 | 487 | 0.270 |
Why?
|
| Wallerian Degeneration | 2 | 2005 | 70 | 0.260 |
Why?
|
| Estrogens | 1 | 2012 | 1562 | 0.260 |
Why?
|
| Male | 40 | 2020 | 349538 | 0.260 |
Why?
|
| Behavior, Animal | 3 | 2020 | 1882 | 0.250 |
Why?
|
| Peripheral Nerves | 2 | 2005 | 474 | 0.240 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 18006 | 0.230 |
Why?
|
| Low Back Pain | 1 | 2011 | 955 | 0.220 |
Why?
|
| Cyclic GMP | 1 | 2004 | 408 | 0.220 |
Why?
|
| Membrane Proteins | 2 | 2010 | 7873 | 0.220 |
Why?
|
| Skull | 2 | 2019 | 810 | 0.210 |
Why?
|
| Interleukin-6 | 1 | 2011 | 3199 | 0.200 |
Why?
|
| Second Messenger Systems | 1 | 2002 | 206 | 0.190 |
Why?
|
| Vasodilator Agents | 1 | 2005 | 976 | 0.190 |
Why?
|
| Receptors, Bradykinin | 1 | 2000 | 19 | 0.190 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 2 | 2012 | 264 | 0.180 |
Why?
|
| Bradykinin | 1 | 2000 | 214 | 0.180 |
Why?
|
| p-Methoxy-N-methylphenethylamine | 2 | 2011 | 41 | 0.180 |
Why?
|
| Neurons | 5 | 2016 | 9325 | 0.180 |
Why?
|
| Trigeminal Nucleus, Spinal | 2 | 2011 | 18 | 0.180 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2002 | 491 | 0.170 |
Why?
|
| Nitric Oxide Donors | 2 | 2013 | 121 | 0.170 |
Why?
|
| Posterior Horn Cells | 2 | 2011 | 87 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2004 | 867 | 0.170 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2010 | 4414 | 0.170 |
Why?
|
| Autonomic Fibers, Postganglionic | 1 | 2018 | 5 | 0.170 |
Why?
|
| Cromakalim | 1 | 2018 | 19 | 0.160 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2019 | 143 | 0.160 |
Why?
|
| Microelectrodes | 2 | 2016 | 303 | 0.160 |
Why?
|
| KATP Channels | 1 | 2018 | 45 | 0.160 |
Why?
|
| Cyclic AMP | 1 | 2002 | 1470 | 0.150 |
Why?
|
| Pituitary Adenylate Cyclase-Activating Polypeptide | 1 | 2018 | 91 | 0.150 |
Why?
|
| Proto-Oncogene Proteins c-fos | 2 | 2011 | 575 | 0.140 |
Why?
|
| Pain Measurement | 3 | 2014 | 3418 | 0.140 |
Why?
|
| Axons | 1 | 2004 | 1681 | 0.140 |
Why?
|
| Ultrasonography, Doppler | 1 | 2018 | 458 | 0.140 |
Why?
|
| Neurotoxins | 2 | 2014 | 237 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 3 | 2018 | 2732 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2018 | 798 | 0.120 |
Why?
|
| Intracranial Pressure | 1 | 2016 | 326 | 0.120 |
Why?
|
| Permeability | 1 | 2016 | 738 | 0.120 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2000 | 960 | 0.120 |
Why?
|
| Astrocytes | 1 | 2021 | 1266 | 0.120 |
Why?
|
| Functional Laterality | 2 | 2014 | 2290 | 0.120 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2018 | 2276 | 0.120 |
Why?
|
| Nitric Oxide Synthase Type II | 3 | 2001 | 534 | 0.110 |
Why?
|
| Enzyme Inhibitors | 4 | 2010 | 3800 | 0.110 |
Why?
|
| Sensory Thresholds | 2 | 2005 | 394 | 0.110 |
Why?
|
| Hindlimb | 1 | 2014 | 505 | 0.110 |
Why?
|
| Neural Conduction | 2 | 2005 | 468 | 0.110 |
Why?
|
| Nitric Oxide Synthase Type III | 2 | 2009 | 689 | 0.110 |
Why?
|
| Constriction, Pathologic | 3 | 2001 | 1095 | 0.110 |
Why?
|
| Tamoxifen | 1 | 1997 | 980 | 0.100 |
Why?
|
| Electrophysiological Phenomena | 1 | 2014 | 316 | 0.100 |
Why?
|
| Blast Injuries | 1 | 2015 | 302 | 0.100 |
Why?
|
| Macrophages | 3 | 2018 | 5655 | 0.100 |
Why?
|
| Ergotamine | 1 | 2011 | 7 | 0.100 |
Why?
|
| Models, Animal | 1 | 2018 | 2170 | 0.100 |
Why?
|
| Neuralgia | 1 | 1998 | 568 | 0.100 |
Why?
|
| Oxygen Consumption | 1 | 2018 | 1869 | 0.100 |
Why?
|
| Calcium | 1 | 2004 | 5753 | 0.100 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2014 | 212 | 0.100 |
Why?
|
| Antibodies | 1 | 2019 | 2459 | 0.090 |
Why?
|
| RNA, Messenger | 3 | 2000 | 13029 | 0.090 |
Why?
|
| Regional Blood Flow | 3 | 2005 | 1525 | 0.090 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2012 | 357 | 0.090 |
Why?
|
| Ovariectomy | 1 | 2012 | 660 | 0.090 |
Why?
|
| Analgesics | 1 | 2016 | 1037 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2000 | 1617 | 0.090 |
Why?
|
| Ectodysplasins | 1 | 2009 | 11 | 0.090 |
Why?
|
| Middle Cerebral Artery | 1 | 2011 | 264 | 0.090 |
Why?
|
| Mice | 6 | 2019 | 81045 | 0.090 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2011 | 292 | 0.090 |
Why?
|
| Military Personnel | 1 | 2018 | 1132 | 0.090 |
Why?
|
| Touch | 1 | 2011 | 306 | 0.090 |
Why?
|
| Alcoholic Intoxication | 1 | 2010 | 188 | 0.080 |
Why?
|
| NG-Nitroarginine Methyl Ester | 2 | 2000 | 255 | 0.080 |
Why?
|
| Pia Mater | 1 | 2009 | 88 | 0.080 |
Why?
|
| Parasympathetic Nervous System | 1 | 2009 | 141 | 0.080 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1997 | 1509 | 0.080 |
Why?
|
| Time Factors | 7 | 2010 | 40054 | 0.080 |
Why?
|
| Nitrobenzenes | 1 | 2008 | 65 | 0.080 |
Why?
|
| Vimentin | 1 | 2009 | 261 | 0.080 |
Why?
|
| Vasoconstriction | 1 | 2011 | 596 | 0.080 |
Why?
|
| Humans | 18 | 2023 | 742088 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2004 | 11363 | 0.080 |
Why?
|
| Prostaglandin D2 | 1 | 2007 | 122 | 0.070 |
Why?
|
| Leukotriene C4 | 1 | 2007 | 97 | 0.070 |
Why?
|
| Epoprostenol | 1 | 2007 | 254 | 0.070 |
Why?
|
| Spleen | 1 | 2012 | 2359 | 0.070 |
Why?
|
| Administration, Topical | 1 | 2008 | 688 | 0.070 |
Why?
|
| Infusions, Intravenous | 2 | 2008 | 2271 | 0.070 |
Why?
|
| Reaction Time | 2 | 2005 | 2092 | 0.070 |
Why?
|
| Blood Vessels | 2 | 2009 | 1124 | 0.070 |
Why?
|
| Histamine | 1 | 2007 | 507 | 0.070 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2005 | 242 | 0.060 |
Why?
|
| Signal Transduction | 2 | 2009 | 23387 | 0.060 |
Why?
|
| Ketorolac | 1 | 2005 | 77 | 0.060 |
Why?
|
| Thionucleotides | 1 | 2004 | 107 | 0.060 |
Why?
|
| Hot Temperature | 2 | 2000 | 1355 | 0.060 |
Why?
|
| Imidazoles | 1 | 2010 | 1205 | 0.060 |
Why?
|
| Oxadiazoles | 1 | 2004 | 93 | 0.060 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2011 | 1440 | 0.060 |
Why?
|
| Carbocyanines | 1 | 2004 | 174 | 0.060 |
Why?
|
| Nitroprusside | 1 | 2004 | 275 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2007 | 10943 | 0.060 |
Why?
|
| Guanylate Cyclase | 1 | 2004 | 201 | 0.060 |
Why?
|
| Denervation | 2 | 2001 | 278 | 0.050 |
Why?
|
| Bucladesine | 1 | 2002 | 121 | 0.050 |
Why?
|
| Differential Threshold | 1 | 2002 | 80 | 0.050 |
Why?
|
| Quinoxalines | 1 | 2004 | 288 | 0.050 |
Why?
|
| Phenotype | 1 | 2019 | 16331 | 0.050 |
Why?
|
| Visual Cortex | 1 | 2010 | 1149 | 0.050 |
Why?
|
| Stress, Mechanical | 1 | 2007 | 1684 | 0.050 |
Why?
|
| Diabetic Neuropathies | 1 | 2005 | 410 | 0.050 |
Why?
|
| Models, Neurological | 1 | 2010 | 1771 | 0.050 |
Why?
|
| Models, Biological | 1 | 2018 | 9581 | 0.050 |
Why?
|
| Nerve Crush | 1 | 2001 | 79 | 0.050 |
Why?
|
| Myelin Sheath | 1 | 2005 | 652 | 0.050 |
Why?
|
| Membrane Potentials | 1 | 2004 | 1135 | 0.050 |
Why?
|
| Receptor, Bradykinin B1 | 1 | 2000 | 10 | 0.050 |
Why?
|
| Receptor, Bradykinin B2 | 1 | 2000 | 24 | 0.050 |
Why?
|
| Microscopy, Electron | 1 | 2004 | 2645 | 0.050 |
Why?
|
| Nerve Endings | 1 | 2000 | 109 | 0.050 |
Why?
|
| T-Lymphocytes | 1 | 2018 | 10163 | 0.050 |
Why?
|
| Anesthesia | 1 | 2011 | 1548 | 0.050 |
Why?
|
| Pyrazoles | 1 | 2010 | 1970 | 0.050 |
Why?
|
| Polyunsaturated Alkamides | 1 | 2019 | 29 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 2004 | 598 | 0.040 |
Why?
|
| Glycerides | 1 | 2019 | 71 | 0.040 |
Why?
|
| Axonal Transport | 1 | 2000 | 177 | 0.040 |
Why?
|
| Female | 6 | 2020 | 379592 | 0.040 |
Why?
|
| Antibodies, Monoclonal | 1 | 2016 | 9274 | 0.040 |
Why?
|
| Arachidonic Acids | 1 | 2019 | 299 | 0.040 |
Why?
|
| Endocannabinoids | 1 | 2019 | 116 | 0.040 |
Why?
|
| Pyridines | 1 | 2010 | 2818 | 0.040 |
Why?
|
| Drug Combinations | 1 | 2004 | 1961 | 0.040 |
Why?
|
| Lumbosacral Region | 1 | 2000 | 310 | 0.040 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1057 | 0.040 |
Why?
|
| Sulfonamides | 1 | 2008 | 1932 | 0.040 |
Why?
|
| Schwann Cells | 1 | 1999 | 195 | 0.040 |
Why?
|
| Wounds and Injuries | 2 | 2001 | 2400 | 0.040 |
Why?
|
| Nerve Net | 1 | 2010 | 2174 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2005 | 1354 | 0.040 |
Why?
|
| Metabolic Clearance Rate | 1 | 1998 | 379 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2010 | 3455 | 0.040 |
Why?
|
| Ganglia, Spinal | 1 | 2000 | 517 | 0.040 |
Why?
|
| Adult | 4 | 2019 | 213712 | 0.040 |
Why?
|
| Guanidines | 1 | 1998 | 191 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2006 | 1093 | 0.040 |
Why?
|
| Adjuvants, Pharmaceutic | 1 | 1997 | 50 | 0.040 |
Why?
|
| Fluorescent Dyes | 1 | 2004 | 1915 | 0.030 |
Why?
|
| Phosphorylation | 1 | 2007 | 8436 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2002 | 3701 | 0.030 |
Why?
|
| Cluster Analysis | 1 | 2002 | 2713 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 1213 | 0.030 |
Why?
|
| Mice, Knockout | 2 | 2019 | 14554 | 0.030 |
Why?
|
| Blotting, Western | 2 | 1999 | 5180 | 0.030 |
Why?
|
| Risk Factors | 2 | 2012 | 72145 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2002 | 1889 | 0.030 |
Why?
|
| Stimulation, Chemical | 1 | 2011 | 326 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 56350 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 213127 | 0.020 |
Why?
|
| Potassium Chloride | 1 | 2010 | 238 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 1997 | 20774 | 0.020 |
Why?
|
| History, 20th Century | 1 | 1997 | 2739 | 0.020 |
Why?
|
| Migraine with Aura | 1 | 2010 | 203 | 0.020 |
Why?
|
| Endometrial Neoplasms | 1 | 1997 | 1351 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 15530 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1999 | 4465 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 415 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 2885 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 1770 | 0.020 |
Why?
|
| Indomethacin | 1 | 2005 | 331 | 0.020 |
Why?
|
| Benchmarking | 1 | 2010 | 1038 | 0.010 |
Why?
|
| Logistic Models | 1 | 1998 | 13403 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2001 | 21821 | 0.010 |
Why?
|
| Skin | 2 | 2007 | 4353 | 0.010 |
Why?
|
| Adolescent | 2 | 2005 | 85649 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 1999 | 170 | 0.010 |
Why?
|
| Brain Mapping | 1 | 2011 | 6669 | 0.010 |
Why?
|
| Biomedical Research | 1 | 2010 | 3306 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2005 | 62966 | 0.000 |
Why?
|
Concepts
(253)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_